Douglass Winthrop Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,576
Closed -$225K 291
2024
Q2
$225K Sell
1,576
-30
-2% -$3.98K ﹤0.01% 263
2024
Q1
$206K Buy
+1,606
New +$191K ﹤0.01% 272
2018
Q3
Sell
-28,600
Closed -$660K 278
2018
Q2
$660K Sell
28,600
-2,600
-8% -$61.8K 0.03% 176
2018
Q1
$768K Sell
31,200
-2,376
-7% -$62.4K 0.04% 161
2017
Q4
$901K Sell
33,576
-5,624
-14% -$143K 0.05% 137
2017
Q3
$944K Hold
39,200
0.05% 125
2017
Q2
$841K Buy
39,200
+2,600
+7% +$52.5K 0.05% 130
2017
Q1
$627K Buy
36,600
+1,000
+3% +$17.4K 0.04% 143
2016
Q4
$638K Buy
35,600
+14,812
+71% +$269K 0.04% 139
2016
Q3
$432K Buy
20,788
+386
+2% +$9.57K 0.03% 168
2016
Q2
$549K Sell
20,402
-2,000
-9% -$54.8K 0.04% 150
2016
Q1
$607K Sell
22,402
-3,000
-12% -$80.4K 0.04% 147
2015
Q4
$738K Buy
25,402
+8,482
+50% +$235K 0.05% 140
2015
Q3
$459K Sell
16,920
-35,270
-68% -$999K 0.04% 164
2015
Q2
$1.39M Hold
52,190
0.11% 97
2015
Q1
$1.39M Buy
52,190
+38,400
+278% +$884K 0.11% 97
2014
Q4
$292K Sell
13,790
-80
-0.6% -$1.79K 0.03% 174
2014
Q3
$330K Sell
13,870
-2,000
-13% -$46K 0.03% 158
2014
Q2
$367K Sell
15,870
-1,000
-6% -$22.1K 0.03% 144
2014
Q1
$385K Buy
+16,870
New +$359K 0.04% 135

Other funds holding NVO